VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q38801221  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241120235814.0
008     241120nneanz||abbn n and d
035 ‎‡a  (WKP)Q38801221‏
024 ‎‡a  0000-0002-5665-5271‏ ‎‡2  orcid‏
024 ‎‡a  56111844900‏ ‎‡2  scopus‏
035 ‎‡a  (OCoLC)Q38801221‏
100 0 ‎‡a  Patrícia Pereira‏ ‎‡9  ast‏ ‎‡9  it‏ ‎‡9  es‏ ‎‡9  sl‏
375 ‎‡a  2‏ ‎‡2  iso5218‏
400 0 ‎‡a  Patrícia Pereira‏ ‎‡c  researcher (ORCID 0000-0002-5665-5271)‏ ‎‡9  en‏
670 ‎‡a  Author's A precision RNA degradation machinery shapes stem cell development‏
670 ‎‡a  Author's Advances in time course extracellular production of human pre-miR-29b from Rhodovulum sulfidophilum.‏
670 ‎‡a  Author's Affinity approaches in RNAi-based therapeutics purification‏
670 ‎‡a  Author's Analysis of pre-miR-29b binding conditions to amino acids by using a surface plasmon resonance biosensor‏
670 ‎‡a  Author's Binding mechanisms for histamine and agmatine ligands in plasmid deoxyribonucleic acid purifications‏
670 ‎‡a  Author's Characterization of polyplexes involving small RNA‏
670 ‎‡a  Author's Cholinium-based Good's buffers ionic liquids as remarkable stabilizers and recyclable preservation media for recombinant small RNAs‏
670 ‎‡a  Author's Chromatographic HPV-16 E6/E7 plasmid vaccine purification employing L-histidine and 1-benzyl-L-histidine affinity ligands‏
670 ‎‡a  Author's Current progress on microRNAs-based therapeutics in neurodegenerative diseases‏
670 ‎‡a  Author's HPV-16 targeted DNA vaccine expression: The role of purification‏
670 ‎‡a  Author's Minicircle DNA purification using a CIM® DEAE-1 monolithic support‏
670 ‎‡a  Author's Naphthalene amine support for G-quadruplex isolation‏
670 ‎‡a  Author's New approach for purification of pre-miR-29 using lysine-affinity chromatography‏
670 ‎‡a  Author's New insights for therapeutic recombinant human miRNAs heterologous production: Rhodovolum sulfidophilum vs Escherichia coli‏
670 ‎‡a  Author's Pharmaceutical-grade pre-miR-29 purification using an agmatine monolithic support‏
670 ‎‡a  Author's Plasmid production and purification: An integrated experiment-based biochemistry and biotechnology laboratory course‏
670 ‎‡a  Author's Preparation of well-defined brush-like block copolymers for gene delivery applications under biorelevant reaction conditions‏
670 ‎‡a  Author's Purification of pre-miR-29 by a new O-phospho-l-tyrosine affinity chromatographic strategy optimized using design of experiments‏
670 ‎‡a  Author's Purification of pre-miR-29 by arginine-affinity chromatography‏
670 ‎‡a  Author's Purification of supercoiled G-quadruplex pDNA for in vitro transcription‏
670 ‎‡a  Author's Recombinant pre-miR-29b for Alzheimer´s disease therapeutics‏
670 ‎‡a  Author's RNA G-quadruplex as supramolecular carrier for cancer-selective delivery‏
670 ‎‡a  Author's Smart micelleplexes as a new therapeutic approach for RNA delivery‏
670 ‎‡a  Author's Stabilization of novel immunoglobulin switch regions G-quadruplexes by naphthalene and quinoline-based ligands‏
909 ‎‡a  (scopus) 56111844900‏ ‎‡9  1‏
909 ‎‡a  (orcid) 0000000256655271‏ ‎‡9  1‏
919 ‎‡a  stabilizationofnovelimmunoglobulinswitchregionsgquadruplexesbynaphthaleneandquinolinebasedligands‏ ‎‡A  Stabilization of novel immunoglobulin switch regions G-quadruplexes by naphthalene and quinoline-based ligands‏ ‎‡9  1‏
919 ‎‡a  smartmicelleplexesasanewtherapeuticapproachforrnadelivery‏ ‎‡A  Smart micelleplexes as a new therapeutic approach for RNA delivery‏ ‎‡9  1‏
919 ‎‡a  rnagquadruplexassupramolecularcarrierforcancerselectivedelivery‏ ‎‡A  RNA G-quadruplex as supramolecular carrier for cancer-selective delivery‏ ‎‡9  1‏
919 ‎‡a  recombinantpremir29bforalzheimersdiseasetherapeutics‏ ‎‡A  Recombinant pre-miR-29b for Alzheimer´s disease therapeutics‏ ‎‡9  1‏
919 ‎‡a  purificationofsupercoiledgquadruplexpdnaforinvitrotranscription‏ ‎‡A  Purification of supercoiled G-quadruplex pDNA for in vitro transcription‏ ‎‡9  1‏
919 ‎‡a  purificationofpremir29byarginineaffinitychromatography‏ ‎‡A  Purification of pre-miR-29 by arginine-affinity chromatography‏ ‎‡9  1‏
919 ‎‡a  purificationofpremir29byanewophospho50tyrosineaffinitychromatographicstrategyoptimizedusingdesignofexperiments‏ ‎‡A  Purification of pre-miR-29 by a new O-phospho-l-tyrosine affinity chromatographic strategy optimized using design of experiments‏ ‎‡9  1‏
919 ‎‡a  preparationofwelldefinedbrushlikeblockcopolymersforgenedeliveryapplicationsunderbiorelevantreactionconditions‏ ‎‡A  Preparation of well-defined brush-like block copolymers for gene delivery applications under biorelevant reaction conditions‏ ‎‡9  1‏
919 ‎‡a  plasmidproductionandpurificationanintegratedexperimentbasedbiochemistryandbiotechnologylaboratorycourse‏ ‎‡A  Plasmid production and purification: An integrated experiment-based biochemistry and biotechnology laboratory course‏ ‎‡9  1‏
919 ‎‡a  pharmaceuticalgradepremir29purificationusinganagmatinemonolithicsupport‏ ‎‡A  Pharmaceutical-grade pre-miR-29 purification using an agmatine monolithic support‏ ‎‡9  1‏
919 ‎‡a  newinsightsfortherapeuticrecombinanthumanmirnasheterologousproductionrhodovolumsulfidophilumvsescherichiacoli‏ ‎‡A  New insights for therapeutic recombinant human miRNAs heterologous production: Rhodovolum sulfidophilum vs Escherichia coli‏ ‎‡9  1‏
919 ‎‡a  newapproachforpurificationofpremir29usinglysineaffinitychromatography‏ ‎‡A  New approach for purification of pre-miR-29 using lysine-affinity chromatography‏ ‎‡9  1‏
919 ‎‡a  naphthaleneaminesupportforgquadruplexisolation‏ ‎‡A  Naphthalene amine support for G-quadruplex isolation‏ ‎‡9  1‏
919 ‎‡a  minicirclednapurificationusingacimdeae1monolithicsupport‏ ‎‡A  Minicircle DNA purification using a CIM® DEAE-1 monolithic support‏ ‎‡9  1‏
919 ‎‡a  hpv16targeteddnavaccineexpressiontheroleofpurification‏ ‎‡A  HPV-16 targeted DNA vaccine expression: The role of purification‏ ‎‡9  1‏
919 ‎‡a  currentprogressonmicrornasbasedtherapeuticsinneurodegenerativediseases‏ ‎‡A  Current progress on microRNAs-based therapeutics in neurodegenerative diseases‏ ‎‡9  1‏
919 ‎‡a  chromatographichpv16e6e7plasmidvaccinepurificationemploying50histidineand1benzyl50histidineaffinityligands‏ ‎‡A  Chromatographic HPV-16 E6/E7 plasmid vaccine purification employing L-histidine and 1-benzyl-L-histidine affinity ligands‏ ‎‡9  1‏
919 ‎‡a  choliniumbasedgoodsbuffersionicliquidsasremarkablestabilizersandrecyclablepreservationmediaforrecombinantsmallrnas‏ ‎‡A  Cholinium-based Good's buffers ionic liquids as remarkable stabilizers and recyclable preservation media for recombinant small RNAs‏ ‎‡9  1‏
919 ‎‡a  characterizationofpolyplexesinvolvingsmallrna‏ ‎‡A  Characterization of polyplexes involving small RNA‏ ‎‡9  1‏
919 ‎‡a  bindingmechanismsforhistamineandagmatineligandsinplasmiddeoxyribonucleicacidpurifications‏ ‎‡A  Binding mechanisms for histamine and agmatine ligands in plasmid deoxyribonucleic acid purifications‏ ‎‡9  1‏
919 ‎‡a  analysisofpremir29bbindingconditionstoaminoacidsbyusingasurfaceplasmonresonancebiosensor‏ ‎‡A  Analysis of pre-miR-29b binding conditions to amino acids by using a surface plasmon resonance biosensor‏ ‎‡9  1‏
919 ‎‡a  affinityapproachesinrnaibasedtherapeuticspurification‏ ‎‡A  Affinity approaches in RNAi-based therapeutics purification‏ ‎‡9  1‏
919 ‎‡a  advancesintimecourseextracellularproductionofhumanpremir29bfromrhodovulumsulfidophilum‏ ‎‡A  Advances in time course extracellular production of human pre-miR-29b from Rhodovulum sulfidophilum.‏ ‎‡9  1‏
919 ‎‡a  precisionrnadegradationmachineryshapesstemcelldevelopment‏ ‎‡A  A precision RNA degradation machinery shapes stem cell development‏ ‎‡9  1‏
946 ‎‡a  a‏ ‎‡9  1‏
996 ‎‡2  LC|n 96067413‏
996 ‎‡2  PTBNP|959002‏
996 ‎‡2  PTBNP|1656202‏
996 ‎‡2  ISNI|000000039084687X‏
996 ‎‡2  PTBNP|1333267‏
996 ‎‡2  PTBNP|1671651‏
996 ‎‡2  PTBNP|1629078‏
996 ‎‡2  ISNI|0000000389544321‏
996 ‎‡2  RERO|A003681730‏
996 ‎‡2  ISNI|0000000069482758‏
996 ‎‡2  NTA|128950358‏
996 ‎‡2  PTBNP|1437155‏
996 ‎‡2  DNB|1218809256‏
996 ‎‡2  PTBNP|1689767‏
996 ‎‡2  LC|no2023120082‏
996 ‎‡2  PTBNP|1378270‏
996 ‎‡2  SUDOC|232342954‏
996 ‎‡2  J9U|987007359553305171‏
996 ‎‡2  SUDOC|198689306‏
996 ‎‡2  BIBSYS|90526208‏
996 ‎‡2  LC|n 2024254979‏
996 ‎‡2  DNB|1296641902‏
996 ‎‡2  LC|no2018010367‏
996 ‎‡2  PLWABN|9811461526605606‏
996 ‎‡2  PLWABN|9812405947705606‏
996 ‎‡2  PTBNP|1461101‏
996 ‎‡2  ISNI|0000000069931525‏
996 ‎‡2  SUDOC|249826712‏
996 ‎‡2  ISNI|0000000070313775‏
996 ‎‡2  BLBNB|000552924‏
996 ‎‡2  SUDOC|246843403‏
996 ‎‡2  PTBNP|1012073‏
996 ‎‡2  BLBNB|001575935‏
996 ‎‡2  ISNI|000000003181274X‏
996 ‎‡2  PTBNP|1386522‏
996 ‎‡2  ISNI|0000000068083181‏
996 ‎‡2  PTBNP|1381842‏
996 ‎‡2  BLBNB|000271849‏
996 ‎‡2  DNB|1217502335‏
996 ‎‡2  ISNI|000000007021278X‏
996 ‎‡2  BLBNB|001487377‏
996 ‎‡2  PTBNP|1472754‏
996 ‎‡2  LC|n 88601475‏
996 ‎‡2  SUDOC|223456918‏
996 ‎‡2  ISNI|0000000070537859‏
996 ‎‡2  LC|n 2018046375‏
996 ‎‡2  PTBNP|1872028‏
996 ‎‡2  ISNI|0000000391978313‏
996 ‎‡2  LC|no2016114070‏
996 ‎‡2  ISNI|0000000358140658‏
996 ‎‡2  PTBNP|938663‏
996 ‎‡2  PTBNP|1251518‏
996 ‎‡2  PTBNP|1679979‏
996 ‎‡2  DNB|1199954365‏
996 ‎‡2  LC|n 2014203838‏
996 ‎‡2  BLBNB|001543614‏
996 ‎‡2  BLBNB|000539042‏
996 ‎‡2  ISNI|0000000082850201‏
996 ‎‡2  ISNI|0000000428245755‏
996 ‎‡2  ISNI|0000000431720422‏
996 ‎‡2  ISNI|0000000068093021‏
996 ‎‡2  DNB|1145675352‏
996 ‎‡2  SUDOC|09511291X‏
996 ‎‡2  PTBNP|910935‏
996 ‎‡2  LC|n 2015238058‏
996 ‎‡2  NTA|362927545‏
996 ‎‡2  PTBNP|1384153‏
996 ‎‡2  BLBNB|000537962‏
996 ‎‡2  PTBNP|1807530‏
996 ‎‡2  BNF|15002602‏
996 ‎‡2  ISNI|0000000069302219‏
996 ‎‡2  PTBNP|1692247‏
996 ‎‡2  BLBNB|000392374‏
996 ‎‡2  PTBNP|1245395‏
996 ‎‡2  PTBNP|1609331‏
996 ‎‡2  PTBNP|1536021‏
996 ‎‡2  PTBNP|147740‏
996 ‎‡2  LC|n 2010041704‏
996 ‎‡2  ISNI|0000000070306006‏
996 ‎‡2  LC|n 2011214013‏
996 ‎‡2  ISNI|0000000454195288‏
996 ‎‡2  NSK|000538313‏
996 ‎‡2  BNF|17940340‏
996 ‎‡2  SUDOC|18516546X‏
996 ‎‡2  LC|no2023028259‏
996 ‎‡2  ISNI|0000000358625997‏
996 ‎‡2  PTBNP|1238423‏
996 ‎‡2  DNB|1213674271‏
996 ‎‡2  RERO|A012345950‏
996 ‎‡2  PTBNP|1862892‏
996 ‎‡2  ISNI|0000000069225575‏
996 ‎‡2  SUDOC|125496389‏
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏